Practicality of Production of 32P by Direct Neutron Activation for Its Utilization in Bone Pain Palliation as Na3[32P]PO4

A Review on Applications of Layered Phosphorus in Energy Storage

Phosphorus in energy storage has received widespread attention in recent years. Both the high specific capacity and ion mobility of phosphorus may lead to a breakthrough in energy storage materials. Black phosphorus, an allotrope of phosphorus, has a sheet-like structure similar to graphite. In this review, we describe the structure and properties of black phosphorus and characteristics of the conductive electrode material, including theoretical calculation and analysis. The research progress in various ion batteries, including lithium-sulfur batteries, lithium–air batteries, and supercapacitors, is summarized according to the introduction of black phosphorus materials in different electrochemical applications. Among them, with the introduction of black phosphorus in lithium-ion batteries and sodium-ion batteries, the research on the properties of black phosphorus and carbon composite is introduced. Based on the summary, the future development trend and potential of black phosphorus materials in the field of electrochemistry are analyzed.

(175)Yb-TTHMP as a good candidate for bone pain palliation and substitute of other radiopharmaceuticals

Bone metastasis is one of the most frequent causes of pain in cancer patients. Different radioisotopes such as P-32, Sm-153, Ho-166, Lu-177, and Re-186 with several chemical ligands as ethylenediaminetetramethylene phosphonic acid (EDTMP), 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetramethylene phosphonic acid (DOTMP), and propylenediaminetetramethylene phosphonate (PDTMP) are recommended for bone pain palliation. In this work, (175)Yb-triethylenetetraminehexamethylene phosphonic acid (TTHMP) was produced as a proper alternative to other radiopharmaceuticals. Relatively long half-life (T1/2 = 4.18 days), maximum energy beta particle Eβ =470 keV (86.5%), low abundance gamma emission 396 keV (6.4%), 286 keV (3.01%), 113.8 keV (1.88%) and low cost are considered advantageous of Yb-175 are to wider usage of this isotope; in addition, TTHMP is an ideal carrier moiety for bone metastases. Production, quality control, and biodistribution studies of (175)Yb-TTHMP were targeted. Yb-175 chloride was obtained by thermal neutron bombardment of a natural Yb2O3 sample at Tehran Research Reactor (TRR), radiolabeling was completed in 1 h by the addition of TTHMP at the room temperature and pH was 7.5-8, radiochemical purity was higher than 95%. Biodistribution studies in normal rats were carried out. The results showed favorable biodistribution features of (175)Yb-TTHMP, indicating significant accumulation in bone tissues compared with clinically used bone-seeking radiopharmaceuticals. This research presents (175)Yb-TTHMP can be a good candidate for bone pain palliation and substitute of other radiopharmaceuticals, however, further biological studies in other mammals are still needed.